Bionet Corp.(TW:1784)
NT$45.00-2.00 (-4.26%)
TW:1784
Bionet Corp. financials statements
NT$45.00
At close:-2.00 (-4.26%)
Bionet Corp. (1784) Income Statement
Bionet Corp. Income Statement
Last quarter (Q2 2026), Bionet Corp.'s total revenue was NT$338.35M, an increase of 11.15% from the same quarter last year. In Q2, Bionet Corp.'s net income was NT$19.80M. See Bionet Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.24B | NT$ 1.22B | NT$ 1.13B | NT$ 980.38M | NT$ 921.42M | |
| NT$ 683.87M | NT$ 685.77M | NT$ 638.28M | NT$ 542.22M | NT$ 503.07M | |
| NT$ 695.98M | NT$ 622.77M | NT$ 553.58M | NT$ 482.25M | NT$ 471.54M | |
| Depreciation and Amortization | NT$ 62.33M | NT$ 45.57M | NT$ 39.60M | NT$ 43.05M | NT$ 38.84M |
| NT$ 47.87M | NT$ 149.09M | NT$ 147.10M | NT$ 113.97M | NT$ 80.41M | |
| NT$ -14.47M | NT$ 62.39M | NT$ 84.69M | NT$ 74.05M | NT$ 41.91M | |
| NT$ 33.74M | NT$ 39.85M | NT$ 22.39M | NT$ -3.59M | NT$ -717.00K | |
| NT$ 19.27M | NT$ 102.24M | NT$ 107.08M | NT$ 70.46M | NT$ 41.19M | |
| NT$ 51.43M | NT$ 83.70M | NT$ 78.40M | NT$ 37.97M | NT$ 26.62M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.02 | NT$ 1.65 | NT$ 1.55 | NT$ 0.80 | NT$ 0.56 |
| Diluted EPS | NT$ 1.02 | NT$ 1.65 | NT$ 1.55 | NT$ 0.80 | NT$ 0.56 |
| Weighted Average Shares Outstanding | 831.00K | 50.65M | 50.58M | 47.24M | 47.53M |
| Weighted Average Shares Outstanding (Diluted) | 831.00K | 50.84M | 50.58M | 47.39M | 47.65M |
Currency in TWD

